Neonatal hypoxia-ischaemia (HI) is the most common cause of death and disability in
human neonates, and is often associated with persistent motor, sensory, and cognitive …

Objectives To examine if therapeutic hypothermia reduces the composite outcome of death,
moderate or severe disability at 18 months or more after mild neonatal encephalopathy …

Background Studies of early childhood outcomes of mild hypoxic-ischemic encephalopathy
(HIE) identified in the first 6 h of life are lacking. Objective To evaluate neurodevelopmental …

OBJECTIVE: More than half of all infants with neonatal hypoxic ischemic encephalopathy
(HIE) are graded as mild and do not meet current criteria for therapeutic hypothermia. These …

Objective To evaluate the safety and short-term outcomes of preterm neonates born at 34-35
weeks gestation with hypoxic-ischemic encephalopathy (HIE) treated with therapeutic …

Objective: To determine short-term outcomes of infants with evidence of hypoxia–ischemia
at birth and classified as mild neonatal encephalopathy (NE) at< 6 h of age. Study Design …

Objective To assess and contrast the incidence and severity of abnormalities on cerebral
magnetic resonance imaging (MRI) between infants with mild, moderate, and severe …

Objective To compare the characteristics and outcomes of neonates with mild hypoxic-
ischemic encephalopathy (HIE) who received hypothermia versus standard care. Study …

Context: Therapeutic hypothermia is the recommended treatment for neonates with
moderate or severe hypoxic ischemic encephalopathy (HIE). There is an increasing trend to …

Background Acute kidney injury (AKI) is common in neonatal encephalopathy (NE) and is
associated with worse outcomes. Our objectives were to determine the incidence, risk …